In:
American Journal of Physiology-Heart and Circulatory Physiology, American Physiological Society, Vol. 299, No. 4 ( 2010-10), p. H1255-H1261
Abstract:
The objective of the present study was to investigate whether pretreatment with single low loading dose of tongxinluo (TXL), a traditional Chinese medicine, 1 h before myocardial ischemia could attenuate no-reflow and ischemia-reperfusion injury by regulating endothelial nitric oxide synthase (eNOS) via the PKA pathway. In a 90-min ischemia and 3-h reperfusion model, minipigs were randomly assigned to the following groups: sham, control, TXL (0.05 g/kg, gavaged 1 h before ischemia), TXL + H-89 (a PKA inhibitor, intravenously infused at a dose of 1.0 μg·kg −1 ·min −1 30 min before ischemia), and TXL + N ω -nitro-l-arginine (l-NNA; an eNOS inhibitor, intravenously administered at a dose of 10 mg/kg 30 min before ischemia). TXL decreased creatine kinase (CK) activity ( P 〈 0.05) and reduced the no-reflow area from 48.6% to 9.5% and infarct size from 78.5% to 59.2% ( P 〈 0.05), whereas these effects of TXL were partially abolished by H-89 and completely reversed by l-NNA. TXL elevated PKA activity and the expression of PKA, Thr 198 phosphorylated PKA, Ser 1179 phosphorylated eNOS, and Ser 635 phosphorylated eNOS in the ischemic myocardium. H-89 repressed the TXL-induced enhancement of PKA activity and phosphorylation of eNOS at Ser 635 , and l-NNA counteracted the phosphorylation of eNOS at Ser 1179 and Ser 635 without an apparent influence on PKA activity. In conclusion, pretreatment with a single low loading dose of TXL 1 h before ischemia reduces myocardial no-reflow and ischemia-reperfusion injury by upregulating the phosphorylation of eNOS at Ser 1179 and Ser 635 , and this effect is partially mediated by the PKA pathway.
Type of Medium:
Online Resource
ISSN:
0363-6135
,
1522-1539
DOI:
10.1152/ajpheart.00459.2010
Language:
English
Publisher:
American Physiological Society
Publication Date:
2010
detail.hit.zdb_id:
1477308-9
SSG:
12
Permalink